Midwest Surgical Association
Surgical, oncologic, and cosmetic differences between oncoplastic and nononcoplastic breast conserving surgery in breast cancer patients

Presented at the 56th Midwest Surgical Association Annual Meeting, July 28–31, 2013, Acme, Michigan.
https://doi.org/10.1016/j.amjsurg.2013.09.017Get rights and content

Abstract

Background

There is a lack of information regarding the safety, complication rate, and cosmetic outcome of oncoplastic breast conserving surgery. The purpose of this study is to evaluate and compare oncoplastic and nononcoplastic procedures.

Methods

A retrospective review was conducted of patients treated with oncoplastic or nononcoplastic lumpectomies. Immediate and long-term complication rates and cosmetic satisfaction were compared.

Results

Of the 142 surgeries, 58 were oncoplastic lumpectomies (40.8%). Oncoplastic patients were younger than nononcoplastic patients (60.9 vs 65.2 years, P = .043). Immediate complications were similar with the exception of nonhealing wounds (oncoplastic = 8.6% vs nononcoplastic = 1.2%, P = .042). Cosmetic complaints were similar, but fat necrosis was more common in the oncoplastic group (25.9% vs 9.5%, P = .009). Time to radiation and number of future biopsies were similar between the groups.

Conclusion

Oncoplastic lumpectomy is a safe alternative to standard lumpectomy for selected breast cancer patients.

Section snippets

Methods

A retrospective review featuring an observational, cohort study design was conducted from a single breast surgeon's records of patients treated with BCS. Medical records of patients diagnosed with breast cancer who underwent a lumpectomy between December 1, 2006 and April 30, 2011 were evaluated to determine if they qualified for study inclusion. Eligible patients were 18 years of age or older, female, and had been treated with lumpectomy, either oncoplastic or nononcoplastic. Subjects were

Results

A total of 140 patients met inclusion criteria and these women underwent 142 lumpectomies. One patient had bilateral cancer and underwent bilateral oncoplastic lumpectomies. An additional patient developed cancer in the contralateral breast at a later date, but still within the study period. There were 58 (40.8%) oncoplastic lumpectomies. Fourteen patients had therapeutic mammoplasty, 43 had adjacent tissue transfer, and 5 had donut mastopexy. Some of these patients received a mixture of

Comments

Oncoplastic lumpectomies have recently become an option for the surgical treatment of breast cancer, but the procedures do require additional time, specialist training, and, overall, can be technically and surgically demanding. This study is unique since it specifically compares both immediate and long-term complications of oncoplastic lumpectomies.

Conclusions

An overall benefit of oncoplastic lumpectomy is that it provides certain patients with more choices for the management of their breast cancer. It offers these patients options that are not only aesthetically more pleasing, but may provide oncological benefit as well. Through this analysis, it has been shown that only minor differences exist between the immediate and long-term complications of the 2 groups; therefore, oncoplastic lumpectomy should be considered a safe alternative for selected

Cited by (91)

View all citing articles on Scopus

The authors declare no conflicts of interest.

View full text